아시아태평양의 유전체 시퀀싱 시장 : 제품별, 최종 사용자별, 국가별 - 분석과 예측(2024-2033년)

Introduction to Asia-Pacific Genome Sequencing Market

The Asia-Pacific genome sequencing market was valued at $1.30 billion in 2024 and is expected to reach $5.96 billion by 2033, growing at a CAGR of 18.44% between 2024 and 2033. Scientists can decipher an organism's entire genetic composition by determining its entire DNA sequence, a process known as genome sequencing. Finding genetic variations and comprehending their possible effects on health and illness require this procedure. Due to rising demand for prenatal and neonatal screening programs using next-generation sequencing (NGS) technologies, growing adoption of genetic testing, and falling sequencing costs, the genome sequencing market in Asia-Pacific is growing quickly.

The market is growing as a result of long-read sequencing's growing applications, which offer more precise and in-depth insights into complicated genetic data. Furthermore, government programs and investments throughout Asia-Pacific are speeding up the adoption of genome sequencing technologies and improving accessibility for medical and scientific applications.

As the area continues to prioritize healthcare advancements, and precision medicine, genome sequencing is emerging as a vital tool for enhancing diagnostics, personalized treatments, and disease prevention. These factors are expected to drive innovation and expand consumer access, shaping the future of the genome sequencing market in APAC.

Market Introduction

The market for APAC genome sequencing is expanding quickly due to improvements in sequencing technology, falling prices, and an increase in the need for genetic testing in the research and healthcare industries. A key component of precision medicine, genome sequencing reveals an organism's entire DNA sequence, facilitating better disease prevention, individualized treatment plans, and enhanced diagnostics.

One of the main factors propelling market expansion is the growing use of next-generation sequencing (NGS) in cancer diagnostics, rare disease identification, and prenatal and neonatal screening. Technologies for long-read sequencing, which offer in-depth understanding of intricate genetic data, are also becoming more popular in the area.

To hasten the adoption of sequencing technologies, governments throughout Asia-Pacific are making significant investments in genomic research and healthcare infrastructure. These programs, along with partnerships among educational institutions and private companies, are enhancing accessibility and innovation.

As the region prioritizes advancements in healthcare and precision medicine, the APAC genome sequencing market is poised for sustained growth, transforming medical research and improving patient outcomes.

Market Segmentation

Segmentation 1: by Product

• Kits
• Instruments
• Software

Segmentation 2: by End User

• Pharmaceutical and Biotechnology Companies
• Hospitals and Diagnostic Laboratories
• Population Sequencing Organizations
• Research and Academic Institutes
• Others

Segmentation 3: by Region

• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest-of-Asia-Pacific

How can this report add value to an organization?

Product/Innovation Strategy: The Asia-Pacific genome sequencing market has been segmented based on various categories, such as by product, end user, and country. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Growth/Marketing Strategy: Partnerships, alliances, funding, new offerings, and business expansions together accounted for the maximum number of key developments of the total developments in the Asia-Pacific genome sequencing market.

Competitive Strategy: The Asia-Pacific genome sequencing market is a highly fragmented market, with many public and few private companies. Key players in the Asia-Pacific genome sequencing market analyzed and profiled in the study involve established players that offer various kinds of products.

Table of Contents

Executive Summary

Scope and Definition

1 Genome Sequencing Market: Industry Analysis

• 1.1 Key Trends: Current and Future Impact Assessment
  • 1.1.1 Integration of Artificial Intelligence and Machine Learning in Genome Sequencing
  • 1.1.2 Increasing Partnerships, Alliances, and Business Expansions among Key Players
• 1.2 Regulatory Analysis
• 1.3 Value and Supply Chain Analysis

2 Genome Sequencing Market: Market Dynamics

• 2.1 Impact Analysis
• 2.2 Market Drivers
  • 2.2.1 Decreasing Cost of Genome Sequencing Enabling High Usage of Genome Sequencing/Testing
  • 2.2.2 Rising Prenatal and New-Born Screening Programs Facilitating the Demand for Next-Generation Sequencing
  • 2.2.3 Expanding Applications of Long-Read Sequencing
  • 2.2.4 Government Investments and Initiatives in Genome Sequencing Projects
• 2.3 Market Restraints
  • 2.3.1 Data Management Challenges in Genome Sequencing
  • 2.3.2 Genomic Data Disparity in Developing Countries
• 2.4 Market Opportunities
  • 2.4.1 Emergence of Portable Genome Sequencing Enabling Bedside Testing
  • 2.4.2 Multiomics Shaping the Global Genome Sequencing Landscape

3 Genome Sequencing Market: Future Outlook

• 3.1 Patent Analysis
  • 3.1.1 Patent Analysis (by Year)
  • 3.1.2 Patent Analysis (by Country)
• 3.2 Competitive Benchmarking
  • 3.2.1 Market Share
  • 3.2.2 Brand Recognition
• 3.3 Sequencing Clinical Adoption
• 3.4 Future Outlook

4 Genome sequencing market (By Region)

• 4.1 Regional Summary
• 4.2 Drivers and Restraints
• 4.3 Asia-Pacific
  • 4.3.1 Regional Overview
  • 4.3.2 Driving Factors for Market Growth
  • 4.3.3 Factors Challenging the Market
  • 4.3.4 By Product
  • 4.3.5 By End User
  • 4.3.6 China
    • 4.3.6.1 By Product
  • 4.3.7 Japan
    • 4.3.7.1 By Product
  • 4.3.8 India
    • 4.3.8.1 By Product
  • 4.3.9 Australia
    • 4.3.9.1 By Product
  • 4.3.10 South Korea
    • 4.3.10.1 By Product
  • 4.3.11 Rest-of-Asia-Pacific
    • 4.3.11.1 By Product

5 Genome sequencing market - Competitive Benchmarking and Company Profiles

• 5.1 Key Strategies and Development
  • 5.1.1 Partnerships, Alliances, and Business Expansions
  • 5.1.2 Regulatory and Legal Activities
  • 5.1.3 New Offerings
  • 5.1.4 Mergers and Acquisitions
  • 5.1.5 Funding Activities
• 5.2 Company Profiles
  • 5.2.1 MGI Tech Co., Ltd.
    • 5.2.1.1 Overview
    • 5.2.1.2 Top Products and Services
    • 5.2.1.3 Top Competitors
    • 5.2.1.4 Key Personnel
    • 5.2.1.5 Analyst View

6 Research Methodology

• 6.1 Data Sources
  • 6.1.1 Primary Data Sources
  • 6.1.2 Secondary Data Sources
  • 6.1.3 Data Triangulation